Women’s Reports of Barriers to and Facilitators of Oral Medication Adherence During Ovarian Stimulation: A Mixed Methods Pilot Study

Background: adherence to lifestyle modification recommendations remains problematic for women undergoing fertility treatment, raising concerns about the extent to which women adhere to prescribed medication regimens. limited data have shown suboptimal oral medication adherence rates of 19% to 74%. the objective of this study was to explore what women perceive as barriers to and facilitators of oral medication adherence during fertility treatment cycles. methods: an exploratory mixed methods pilot study was conducted among a sample of 30 women who were actively taking one to two cycles of letrozole or clomiphene citrate for ovarian stimulation in conjunction with intrauterine insemination cycles. medication adherence barriers were measured using a 20-item survey. medication adherence facilitators and personal experiences with fertility treatment were assessed with structured interviews. medication adherence was assessed with electronic event monitoring. results: the overall medication adherence median was 0.97 with a range of 0.75 to 1.00, and nine women (50%) demonstrated perfect adherence. the most commonly reported barriers were recently feeling sad, down, or blue (53%), and taking medication more than once per day (40%). women with higher barrier scores had significantly lower medication adherence scores (p=0.02) compared to women with lower total barrier scores. facilitators included using physical aides as reminders (60%) and establishing a daily routine (50%). no significant correlation was found between medication adherence scores and facilitators. conclusion: the dynamic interplay between perceived barriers and facilitators and women’s medication-taking patterns could influence whether or not medication regimens are followed correctly.